Latest "MAQUET Cardiovascular LLC" News Stories

17:09 EST 13th December 2018 | BioPortfolio

Here are the most relevant search results for "MAQUET Cardiovascular LLC" found in our extensive news archives from over 250 global news sources.

More Information about MAQUET Cardiovascular LLC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MAQUET Cardiovascular LLC for you to read. Along with our medical data and news we also list MAQUET Cardiovascular LLC Clinical Trials, which are updated daily. BioPortfolio also has a large database of MAQUET Cardiovascular LLC Companies for you to search.

Showing "MAQUET Cardiovascular" News Articles 1–25 of 3,100+

Thursday 13th December 2018

Global Suture Needles Market 2019-2023 | Increasing Healthcare Expenditure Drives Growth | Technavio

Technavio’s global suture needles market research report projects the market to grow at a CAGR of over 4% during the forecast period. This press release features multimedia. View the full release here: Technavio has released a new market research report on the global suture nee

Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease

RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 13, 2018 — The Duke Clinical Research Institute (DCRI) is leading a new clinical study to optimize care for people with type 2 diabetes and cardiovascular disease through evaluation of a multidisciplinary approach at cardiology clinics across the U.S.

New Therapeutic Area Leaders Extend PPD’s Drug Development Capabilities

Enhancing the Global CRO’s Expertise in Cardiovascular Disease, Critical Care, Endocrinology, Metabolism and Diabetes Pharmaceutical Product Development, LLC (PPD) is adding significant

Johnson Johnson JNJ Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryJohnson Johnson JJ researches and develops, and manufactures and sells a range of pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in baby care, oral care, beauty, overthecounter OTC pharmaceutical, women's health and ...

Cardiovascular Outcomes Trials Give 'Comforting' Results

Dr Anne Peters gives us her take on the recent CARMELINA, DECLARE-TIMI, and REWIND trials and their cardiovascular outcomes. Medscape Diabetes & Endocrinology

Pregnancy Losses Linked to Risk for Cardiovascular Disease

THURSDAY, Dec. 13, 2018 -- Both pregnancy losses and a history of at least five live births are associated with an increased risk for cardiovascular disease, according to a study published online Nov. 27 in the Journal of Women's Health. Clare...

Cipla Ltd CIPLA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCipla Ltd Cipla is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients APIs. It offers products for the treatment of various conditions such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, malaria, cancer, ne...

PPD Adds New Therapeutic Area Leaders

Enhances drug development capabilities in cardiovascular disease, critical care, endocrinology, metabolism and diabetes

Wednesday 12th December 2018

The Medicines Company Announces Intention to Offer $150 Million of Convertible Notes

The Medicines Company (NASDAQ:MDCO) (the “Company”) today announced that it proposes to offer $150 million aggregate principal amount of convertible senior notes due 2024, subject to market conditions and other factors. The notes are to be offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as...

Cardiovascular Disease Linked to Living Close to Oil and Gas Exploration

ArticleAdvances in fracking, horizontal drilling and micro-seismic imaging has opened up several previously inaccessible areas for exploration, some of which are in heavily populated areas.

Singulex Receives New, Broad Patent for Highly Sensitive Methods for Analysis of Troponin

Singulex announced today the granting of a significant European patent (EP 3168618) covering methods for determining myocardial infarction using any high sensitivity cardiac troponin assay with a sensitivity < 5 pg/mL. “The global clinical market is rapidly adopting high sensitivity cardiac troponin assays to better manage patients suspected ...

Luye Pharma's Global Strategy For CNS-Focused Products Gathers Pace: Rotigotine Extended Release Microspheres Submitted to Japan's PMDA for Clinical Trial Approval

SHANGHAI, Dec. 12, 2018 /PRNewswire/ -- Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003) for the treatment of Parkinson's disease has been submitted to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for clinical trial approval. Meanwhile Phase III clinical trials for LY03003 in the U.S. and China are progressi...

Our Nation’s Health: Obesity Rate at All-Time High; Childhood Poverty Continues to Decline

Hawaii is the healthiest state in 2018; Louisiana faces most challenges New tool helps states understand key health insights to improve their overall rank The nation’s obesity rate has reached the highest-ever level this year, according to the United Health Foundation’s 2018 America’s

VisionQuest Biomedical LLC Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryVisionQuest Biomedical LLC VisionQuest is a medical device company that develops medical imaging tools for the diagnostic services. The company's products include eyestar, DRRACS, and neurotherm. Its eyestar product is a total eye disease screening program package, DRRACS is an automated analysis tool used to increase EyeStar report throughput and neurotherm is an infrared device for early ...

What Matters More — Intensity or Adherence to Lipid-Lowering Therapy?

A combined measure of treatment intensity and adherence had a graded relationship with cardiovascular outcomes in an observational study.

Recordati SpA REC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryRecordati SpA Recordati, a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculoskeletal disorders and analgesia and urology diseases. It also offers cosmetics, dietary supplements, pregnancy test products, ...

TissueGen Inc Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryTissueGen Inc TissueGen is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company's products comprise pharmaceutical fibers, growth factor fibers and stent. It offers pharmaceutical fibers and growth factor fibers. TissueGen's products are used in sciatic nerve repair, peripheral nerve regeneration, spinal cord repair, ...

VBCs: Are They Working?

As an observer, it can be difficult to find out what’s happening with value-based contracts (VBCs). The fanfare that accompanies the announcement of a deal invariably gives way to a long period of silence, a good sign if you subscribe to the mantra that no news is good news, but if you don’t, there is cause for concern. The smattering of reports on the topic suggest that green shoots are emerg...

Manipal Hospital Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryManipal Hospital, formerly Manipal Health Systems is a healthcare service provider that offers primary, secondary and tertiary healthcare services. The hospital offers services such as robotic assisted surgery, eye care, rehabilitation, skin care, accident and emergency care, child care, dental care, home healthcare, and others. It provides services in the areas of cardiovascular, neurology...

Tuesday 11th December 2018

Pesticide exposure raises risk for cardiovascular disease among Latino workers

(University of Illinois at Chicago) Latinos who are exposed to pesticides in their workplaces are twice as likely to have cardiovascular disease compared with Latinos who are not exposed to pesticides at work, according to a new study published in the journal Heart.

Hearing loss is a risk factor for premature death

(Columbia University's Mailman School of Public Health) A new study links hearing loss with an increased risk for mortality before the age of 75 due to cardiovascular disease. Researchers found that mortality among those with hearing loss is elevated, particularly among men and women younger than age 75 and those who are divorced or separated. However, mortality risk was diminished in adults with ...

Yes to yoghurt and cheese: New improved Mediterranean diet

Thousands of Australians can take heart as new research from the University of South Australia shows a dairy-enhanced Mediterranean diet will significantly increase health outcomes for those at risk of cardiovascular disease – and it’s even more effective than a low-fat diet.

Female STEMI patients wait 37 minutes longer than men to seek help

Women suffering ST-segment elevation MI (STEMI) wait on average 37 minutes longer than men to call for help, according to research published in the European Heart Journal: Acute Cardiovascular Care.

Vitamin D Receptor Activator Doesn't Lower CV Risk in Some Patients on Hemodialysis

Oral alfacalcidol, a vitamin D receptor activator (VDRA), is not associated with reduced cardiovascular risk among patients without secondary hyperparathyroidism receiving maintenance hemodialysis, a JAMA...

Bay Labs, Edwards team up in cardiovascular disease detection

Bay Labs Inc. and Edwards Lifesciences Corp. are teaming up to use artificial intelligence (AI) to develop better ways to det...

Quick Search


News Quicklinks